Protocol Status: PUBLISHED
Protocol:
Version: 2026.01
Effective Date:
Last Reviewed:
Medical Director Approval:
Clinical Note: This content reflects current GCEMS clinical guidelines as of the dates listed above. If content appears inconsistent with current policy, use the most recent approved guideline and notify leadership for correction.

Naloxone

(Narcan)

 

Indications:

 

  • Narcotic Overdose
    • Narcotic Overdoses
    • Synthetic Analgesic Overdose

 

Contraindications:

 

  • Known Hypersensitivity

 

Side Effects:

 

  • Vomiting with rapid administration
  • Ventricular Dysrhythmias
  • Precipitate acute narcotic withdrawal syndrome
  • Seizures
  • Hypertension

 

Adult Dose:

 

  • 1 - 2 mg slow IV/IO/IM titrated to respirations; max 4 mg

 

PEDIATRIC:

 

  • 0.1 mg/kg  max 2 mg; may repeat every 2-3 minutes as needed
  • 4 mg IN, may repeat once